Leone, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 11.249
NA - Nord America 10.309
AS - Asia 4.064
SA - Sud America 557
OC - Oceania 168
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.452
Nazione #
US - Stati Uniti d'America 10.131
DE - Germania 5.133
CN - Cina 2.014
SE - Svezia 1.577
SG - Singapore 1.107
UA - Ucraina 1.077
IT - Italia 820
FR - Francia 555
GB - Regno Unito 515
BR - Brasile 478
IE - Irlanda 384
PL - Polonia 353
IN - India 251
FI - Finlandia 243
ID - Indonesia 222
RU - Federazione Russa 166
TR - Turchia 165
AU - Australia 143
CA - Canada 115
NL - Olanda 79
JP - Giappone 52
BE - Belgio 49
CI - Costa d'Avorio 49
ES - Italia 49
MX - Messico 44
AR - Argentina 40
VN - Vietnam 34
IR - Iran 28
CH - Svizzera 26
AT - Austria 25
HK - Hong Kong 25
NZ - Nuova Zelanda 25
KR - Corea 24
NO - Norvegia 22
RO - Romania 22
GR - Grecia 16
HU - Ungheria 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
IL - Israele 14
BD - Bangladesh 13
CZ - Repubblica Ceca 12
LT - Lituania 12
PT - Portogallo 12
ZA - Sudafrica 12
IQ - Iraq 10
LV - Lettonia 10
SK - Slovacchia (Repubblica Slovacca) 10
EG - Egitto 9
MA - Marocco 9
CL - Cile 8
CO - Colombia 8
EC - Ecuador 8
HR - Croazia 8
DZ - Algeria 7
EU - Europa 7
JO - Giordania 7
RS - Serbia 7
TH - Thailandia 6
UZ - Uzbekistan 6
BA - Bosnia-Erzegovina 5
DK - Danimarca 5
LB - Libano 5
LK - Sri Lanka 5
LU - Lussemburgo 5
MK - Macedonia 5
MY - Malesia 5
NP - Nepal 5
SA - Arabia Saudita 5
TW - Taiwan 5
AM - Armenia 4
AZ - Azerbaigian 4
BZ - Belize 4
GE - Georgia 4
KG - Kirghizistan 4
PE - Perù 4
PK - Pakistan 4
PS - Palestinian Territory 4
UY - Uruguay 4
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
ME - Montenegro 3
PH - Filippine 3
SI - Slovenia 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
IS - Islanda 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
Totale 26.433
Città #
Chandler 1.609
Ashburn 727
Jacksonville 701
Singapore 656
Nanjing 454
San Mateo 451
Dearborn 448
Dublin 371
Ann Arbor 352
Nürnberg 335
Warsaw 316
Houston 276
Woodbridge 272
Wilmington 249
Beijing 214
Jakarta 209
Milan 202
New York 194
Seattle 189
Hangzhou 183
Nanchang 179
Los Angeles 168
Redwood City 154
Lawrence 148
Munich 147
Boston 136
Izmir 133
Bremen 131
Marseille 120
Moscow 110
Fairfield 107
Kunming 101
Lancaster 101
Cattolica 81
Shenyang 81
Zhengzhou 74
Rome 69
University Park 67
Chicago 66
Hebei 63
Tianjin 62
Guangzhou 61
Leawood 59
Princeton 57
Mountain View 56
Hefei 54
Changsha 50
Abidjan 49
Frankfurt am Main 49
Auburn Hills 47
Redmond 47
Jiaxing 46
Norwalk 46
Boardman 43
Brussels 43
Shanghai 43
Philadelphia 38
Cambridge 37
Pune 36
São Paulo 36
Jinan 35
Fremont 34
Helsinki 34
Düsseldorf 33
London 33
Sydney 33
San Francisco 30
Augusta 28
Brooklyn 28
Buffalo 27
Melbourne 27
Phoenix 27
Toronto 27
Portland 24
San Diego 24
Detroit 23
Lanzhou 23
Simi Valley 23
Adelaide 22
Brisbane 22
Hong Kong 22
Changchun 21
San Jose 21
Hanoi 20
Chatsworth 19
Portsmouth 18
Santa Clara 18
Amsterdam 17
Berlin 17
Paris 17
Wayne 17
Belo Horizonte 16
Costa Mesa 16
Federal 16
Mexico 16
Tobarra 16
Tokyo 16
Washington 16
Atlanta 15
Ningbo 14
Totale 12.508
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.619
Incidence of acute myeloid leukemia after breast cancer 340
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 310
Factors associated with mortality in bacteremic patients with haematologic malignancies 307
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 244
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 239
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 233
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 224
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 217
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 217
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 212
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 198
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 192
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 189
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 187
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 177
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 177
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 173
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 172
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 172
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 171
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 170
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 166
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 162
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 161
Von hippel-lindau disease and erythrocytosis 160
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 156
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 155
Correlation between paraproteinaemia and viral reactivation after allo-SCT 154
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 150
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 148
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 146
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 145
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 144
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 144
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 144
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 143
Why methylation is not a marker predictive of response to hypomethylating agents 143
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 142
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 141
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 139
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 139
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 139
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 138
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 138
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 137
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 137
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 137
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 136
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 136
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 135
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 134
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 133
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 132
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 132
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 132
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 131
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 131
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 131
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 131
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 131
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 130
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 129
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 129
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 127
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 127
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 127
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 127
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 126
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 126
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 126
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 125
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 125
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 125
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 122
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 121
Primary plasma cell leukemia followed by testicular plasmacytoma 120
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 119
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 118
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 117
Epigenetic changes in therapy-related MDS/AML 117
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 117
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 117
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 116
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 116
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 116
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 116
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 115
Similarities and differences between therapy-related and elderly acute myeloid leukemia 115
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 115
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 114
Iron in Hodgkin's lymphoma 114
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 114
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 113
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 113
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 112
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 112
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 112
Totale 17.371
Categoria #
all - tutte 89.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020550 0 0 0 0 0 0 0 0 0 0 277 273
2020/20212.596 94 279 64 242 293 211 322 59 286 155 526 65
2021/20222.084 219 240 37 106 138 77 53 345 85 137 283 364
2022/20234.368 520 641 333 725 310 530 225 344 510 46 118 66
2023/20242.558 103 573 87 110 149 387 124 104 102 178 358 283
2024/20253.638 322 249 398 180 441 120 142 210 672 338 566 0
Totale 26.582